Skip to main content

BioSolveIT, Molecular Networks Form North American Marketing Pact

NEW YORK (GenomeWeb News) - BioSolveIT has signed a collaboration and marketing agreement with Molecular Networks covering both companies' product sales in North America, BioSolveIT said today.
 
The German cheminformatics companies agreed that BioSolveIT will market Molecular Networks' products in the US and in Canada. BioSolveIT’s US sales representative is now the point person for North American license inquiries for both companies.
 
BioSolveIT makes software that is used for "structure-based design, flexible molecular alignment, database searching, library design, and analysis," including the FlexX docking software.
 
Molecular Networks offers cheminformatics software, consulting and R&D services, including the 3D structure generation tool Corina.
 
"There is a great deal of synergy between the software portfolios of our two companies," said Molecular Networks' CEO, Johann Gasteiger.
 
BioSolveIT's CEO Christian Lemmen said the agreement will allow the companies to "better coordinate our marketing efforts for the benefit of our end-user customers."

The Scan

Possibly as Transmissible

Officials in the UK say the B.1.617.2 variant of SARS-CoV-2 may be as transmitted as easily as the B.1.1.7 variant that was identified in the UK, New Scientist reports.

Gene Therapy for SCID 'Encouraging'

The Associated Press reports that a gene therapy appears to be effective in treating severe combined immunodeficiency syndrome.

To Watch the Variants

Scientists told US lawmakers that SARS-CoV-2 variants need to be better monitored, the New York Times reports.

Nature Papers Present Nautilus Genome, Tool to Analyze Single-Cell Data, More

In Nature this week: nautilus genome gives peek into its evolution, computational tool to analyze single-cell ATAC-seq data, and more.